SCHEMBL8444474

SCHEMBL8444474

CC(C)N(C(=O)c1ccc2c(-c3cnc4ccc(N)cn34)nn(C)c2c1)C(C)C

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 9/20 0.54
SCN9A Q15858 5/20 0.41
SCN5A Q14524 2/20 0.39
KDM4E B2RXH2 1/20 0.33
ALDH1A1 P00352 1/20 0.33
LMNA P02545 1/20 0.33
MAPT P10636 1/20 0.33
HPGD P15428 1/20 0.33
MCOLN3 Q8TDD5 1/20 0.33
MKNK1 Q9BUB5 1/20 0.33
MKNK2 Q9HBH9 1/20 0.33
LTB4R Q15722 1/20 0.32
RXRA P19793 1/20 0.32
RIPK2 O43353 1/20 0.32
PIK3CD O00329 1/20 0.31
PIK3CA P42336 1/20 0.31
PIK3CB P42338 1/20 0.31
MTOR P42345 1/20 0.31
PIP4K2A P48426 1/20 0.31
PIK3CG P48736 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1355355 0.87 ADORA2A (0.62) ADORA2ASCN9ASCN5AMKNK1MKNK2
SCHEMBL8444460 0.82 ADORA2A (0.78) ADORA2AHPGDMKNK1MKNK2
SCHEMBL8446498 0.81 ADORA2A (0.80) ADORA2AHPGDMKNK1MKNK2
SCHEMBL8448329 0.81 ADORA2A (0.80) ADORA2AHPGDMKNK1MKNK2
SCHEMBL1353175 0.80 ADORA2A (0.64) ADORA2ASCN9ASCN5ARXRA
SCHEMBL13284352 0.76 ADORA2A (0.81) ADORA2A
SCHEMBL13284350 0.76 ADORA2A (0.81) ADORA2A
SCHEMBL1355537 0.75 ADORA2A (0.74) ADORA2ASCN9AKDM4E
SCHEMBL1353250 0.74 ADORA2A (0.64) ADORA2AKDM4ELMNAHPGDMKNK1
SCHEMBL1355334 0.73 ADORA2A (0.65) ADORA2AMKNK1MKNK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010084425-A1 NEW ADENOSINE RECEPTOR LIGANDS AND USES THEREOF DOMAIN THERAPEUTICS (FR) 2010-07-29 WO disclosed
EP-2210891-A1 New adenosine receptor ligands and uses thereof Domain Therapeutics (FR) 2010-07-28 EP disclosed